BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2091 related articles for article (PubMed ID: 17242396)

  • 1. Revised response criteria for malignant lymphoma.
    Cheson BD; Pfistner B; Juweid ME; Gascoyne RD; Specht L; Horning SJ; Coiffier B; Fisher RI; Hagenbeek A; Zucca E; Rosen ST; Stroobants S; Lister TA; Hoppe RT; Dreyling M; Tobinai K; Vose JM; Connors JM; Federico M; Diehl V;
    J Clin Oncol; 2007 Feb; 25(5):579-86. PubMed ID: 17242396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
    Cheson BD; Fisher RI; Barrington SF; Cavalli F; Schwartz LH; Zucca E; Lister TA; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    J Clin Oncol; 2014 Sep; 32(27):3059-68. PubMed ID: 25113753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D; Stroobants S; de Kerviler E; Gisselbrecht C; Meignan M; Conti PS
    Oncologist; 2009; 14 Suppl 2():30-40. PubMed ID: 19819922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
    Spaepen K; Mortelmans L
    Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant lymphoma].
    Okamoto R
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2532-6. PubMed ID: 20009452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
    Specht L
    Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME
    J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of interim (18)F-fluorodeoxyglucose PET to guide therapy in lymphoma.
    Araf S; Montoto S
    Future Oncol; 2013 Jun; 9(6):807-15. PubMed ID: 23718301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in the treatment of Hodgkin's disease and malignant non-Hodgkin's lymphoma].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S88-95. PubMed ID: 12739340
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P; Sica S; Leone G
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response assessment in lymphoma.
    Hampson FA; Shaw AS
    Clin Radiol; 2008 Feb; 63(2):125-35. PubMed ID: 18194687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.
    Cheson BD; Horning SJ; Coiffier B; Shipp MA; Fisher RI; Connors JM; Lister TA; Vose J; Grillo-López A; Hagenbeek A; Cabanillas F; Klippensten D; Hiddemann W; Castellino R; Harris NL; Armitage JO; Carter W; Hoppe R; Canellos GP
    J Clin Oncol; 1999 Apr; 17(4):1244. PubMed ID: 10561185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
    Weber WA
    J Nucl Med; 2007 Oct; 48(10):1580-2. PubMed ID: 17909256
    [No Abstract]   [Full Text] [Related]  

  • 17. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
    Bennani-Baiti B; Yadav S; Flynt L; Bennani-Baiti N
    J Clin Oncol; 2015 Apr; 33(10):1216-7. PubMed ID: 25691676
    [No Abstract]   [Full Text] [Related]  

  • 18. The International Harmonization Project for response criteria in lymphoma clinical trials.
    Cheson BD
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):841-54. PubMed ID: 17908623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC
    J Clin Oncol; 2015 Apr; 33(10):1217. PubMed ID: 25691675
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
    Johnston PB; Wiseman GA; Micallef IN
    Bone Marrow Transplant; 2008 Jun; 41(11):919-25. PubMed ID: 18391991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.